Photobiomodulation, often abbreviated PBM, describes the use of non-ionizing light to influence cellular activity. The term is commonly associated with red and near-infrared light, although the broader field of light-based skincare also includes blue light for acne-focused use.
Unlike ultraviolet radiation, the wavelengths used in typical LED skincare devices are non-ionizing. Unlike ablative lasers or intense pulsed light, PBM is generally designed to work without producing a destructive thermal injury. Light is absorbed by naturally occurring molecules within tissue, known as chromophores or photoacceptors, initiating biological responses that may influence cellular energy, signaling, circulation, inflammation, and tissue remodeling.
The response is not unlimited: more light is not necessarily better. PBM is often described as having a biphasic dose response, meaning an insufficient dose may do little while an excessive dose may reduce the desired response. This is why wavelength alone never tells the entire story.
When light reaches the skin, some is reflected, some is scattered, and some is absorbed. The proportion that penetrates depends on wavelength as well as skin composition, pigmentation, device geometry, distance from the skin, and other variables. In general, longer red and near-infrared wavelengths penetrate more deeply than shorter blue wavelengths, but penetration is gradual rather than a precise boundary at a particular skin
layer.
Red and near-infrared light are widely studied for their interaction with mitochondrial and cellular signaling pathways. Cytochrome c oxidase has often been proposed as an important photoacceptor, particularly for red and near-infrared light. Research also describes changes involving nitric oxide, reactive oxygen species, membrane channels, gene expression, and downstream signaling. These pathways may influence ATP availability, microcirculation, inflammatory signaling, fibroblast activity, and extracellular matrix processes.
The science continues to evolve, and no single mechanism explains every observed effect across all wavelengths, tissues, devices, and treatment protocols. A responsible explanation therefore distinguishes established physical principles from mechanisms that remain under active investigation.
Blue light is most commonly associated with mild-to-moderate
acne. Certain wavelengths can excite porphyrins produced by Cutibacterium
acnes, leading to reactive species that can reduce the bacteria associated with
inflammatory acne. Because blue light penetrates less deeply than red or
near-infrared light, its action is comparatively superficial. Some devices
combine blue and red light to pair an acne-focused antibacterial mechanism with
the supportive biological effects associated with red light.
Evidence is encouraging, but systematic reviews have also
noted that many studies are small, short, or methodologically inconsistent.
Blue light should therefore be presented as a technology with an acne-focused
evidence base—not as a universal solution for every type or severity of acne.
Red light is the best-known wavelength family in cosmetic
photobiomodulation. Studies have evaluated it for visible wrinkles, skin
roughness, complexion, elasticity, and markers associated with collagen and
tissue remodeling. Red light may support cellular energy and signaling without
the downtime associated with procedures designed to injure or remove tissue.
The most frequently encountered red wavelengths in skincare devices are near 630, 633, and 660 nanometers. These numbers are not interchangeable marketing labels: the device must also deliver a consistent,
appropriately distributed intensity and dose.
Near-infrared light lies just beyond the visible spectrum. Although we cannot see it, tissue can absorb and respond to it. Because these longer wavelengths generally penetrate more deeply than visible blue and red light, near-infrared light is often paired with red light in devices designed to support skin vitality and the visible signs of aging. Common home-use wavelengths include approximately 830, 850, and sometimes 940 nanometers.
A higher wavelength does not automatically mean a better device. Evidence, output, dose, coverage, thermal management, optical design, and intended use must all be considered together.
Civilizations used sunlight in health practices long before its components were understood scientifically.
Scientific interest accelerated as researchers began separating and studying portions of the light spectrum. Physician Niels Ryberg Finsen became closely associated with modern phototherapy and received the 1903 Nobel Prize in Physiology or Medicine for treating disease with concentrated light radiation.
After the laser was developed in 1960, researchers investigated whether low-intensity light could influence tissue without heating or destroying it. Early work helped establish the field once called low-level laser therapy.
Light-emitting diodes made it possible to deliver selected wavelength bands across larger treatment areas with less complex equipment. Improvements in LED output, consistency, and wearability contributed to the rise of masks, panels, and handheld devices.
The term photobiomodulation increasingly replaced older labels because it describes the biological objective rather than a particular light source. PBM is now studied across dermatology, supportive care, wound healing, pain, oral mucositis, and other fields, although the evidence and regulatory status differ by indication.
The scientific literature includes controlled trials, split-face studies, home-use studies, histological evaluations, and systematic reviews. Taken together, the research supports the biological plausibility of photobiomodulation and suggests that properly designed red and near-infrared protocols can improve certain visible measures of photoaging. Blue light has evidence for mild-to-moderate inflammatory acne, particularly in selected protocols and combination regimens.
Controlled clinical studies have reported improvements in measures such as skin roughness, complexion, elasticity, collagen density, wrinkle appearance, and participant-reported skin feel after repeated red or red-plus-near-infrared treatment. Some studies include objective profilometry, ultrasound, histology, or other instrumental measurements; others rely more heavily on photographs and self-assessment.
Blue-light and combined blue/red protocols have demonstrated reductions in inflammatory acne lesions in multiple studies. However, reviews have emphasized variation in wavelengths, dosing schedules, comparators, treatment duration, and study quality. Acne can also have hormonal, inflammatory, and structural components that light alone may not address.
A positive study does not validate every device that uses the same color of light. Results apply most directly to the tested wavelength, irradiance, dose, treatment frequency, treatment area, and device configuration. Small studies, short follow-up periods, inconsistent outcome measures, and manufacturer sponsorship are common limitations in this category.
Our standard
We look for alignment among the device specifications, intended use, published evidence, regulatory position, and the treatment experience—not a single impressive number or isolated study.
For a device operating continuously at a measured irradiance of 20 mW/cm² for 10 minutes, the nominal dose is:
20 mW/cm² × 600 seconds ÷ 1,000 = 12 J/cm²
This calculation is useful, but it does not correct for uneven coverage, distance, curvature, pulsing, or optical losses. Reliable manufacturers should explain how and where output was measured.
Within a careful cosmetic and educational framework, light therapy may be discussed in relation to:
The precise claims made for a marketed device must match its evidence, labeling, and regulatory status. Phrases such as “FDA approved” should never be used loosely. Many light-therapy medical devices enter the U.S. market through 510(k) clearance, which is different from approval.
LED light therapy is generally well tolerated when a properly designed device is used according to its instructions. Nevertheless, light is biologically active, and suitability depends on the individual, the device, and the intended use.
A Note on Eye Safety
Eye safety deserves particular attention because visible brightness is not a reliable measure of retinal exposure, and near-infrared output is invisible. The correct protection depends on wavelength, intensity, geometry, labeling, and the device’s validated design.
A sophisticated exterior is only the beginning. Our evaluation considers whether the technology, specifications, evidence, user experience, and claims make sense together.
Purpose: What is the device designed to do, and is that use clearly defined?
Wavelengths: Are the peak wavelengths and tolerances disclosed, and are they relevant to the intended benefit?
Measured Output: Is irradiance reported at the treatment surface, with a clear method and appropriate test equipment?
Dose and Protocol: Do intensity, session length, frequency, and duration align with the supporting evidence?
Coverage: Does the design deliver light evenly across the intended area, including facial contours?
Evidence: Are there device-specific studies and appropriate predicate comparisons?
No. Both can use selected wavelengths, but lasers and LEDs
differ in coherence, beam characteristics, output, device design, and clinical
use. PBM can be delivered by either source; effectiveness depends on
appropriate treatment parameters rather than the word “laser” alone.
No. Visible brightness reflects human visual sensitivity, not therapeutic dose. Near-infrared light may be biologically relevant even though it is invisible. Wavelength, measured irradiance, dose, uniformity, and protocol are more meaningful.
Only if the device instructions support daily use. Appropriate frequency varies by wavelength, dose, indication, and device design. More frequent use is not automatically more effective.
Some users notice a temporary sense of radiance or calmness
quickly, but changes in visible wrinkles, texture, or firmness generally
require repeated use over weeks. Acne-focused outcomes also require consistent
treatment and may depend on the type and severity of acne.
Follow the device instructions. Some protocols specify clean, dry skin; others are designed to be used with compatible products. Avoid combining light with an ingredient known to cause photosensitivity unless the device maker and a qualified professional consider the combination appropriate.
Near-infrared wavelength and heat are not the same thing. A PBM device may feel warm because LEDs and electronics generate heat, but PBM is generally intended to produce a non-destructive, non-thermal biological response. Excessive heat is not evidence of greater effectiveness.
Light therapy is compelling because it transforms an elemental force into a precise skincare tool. Its elegance lies not in spectacle, but in control: selected wavelengths, measured energy, thoughtful engineering, and consistent use.
At Proaging Technology, we believe innovation should be understandable. We look beyond the number of LEDs, the brightness of the glow, and the excitement of a trend to ask a more meaningful question: does the complete treatment system have a clear purpose, credible evidence, and a place in a considered skincare ritual?
Beauty technology is most powerful when its science is clear, its purpose is honest, and its use respects the skin.
These links are intended as accessible starting points for readers who wish to explore the underlying science. They do not imply that every finding applies to every consumer device.
Unlocking the Power of Light on the Skin. A 2024 open-access review discussing light-tissue interactions and dermatologic applications View source
Photobiomodulation—Underlying Mechanism and Clinical Applications. A 2020 open-access review of proposed mechanisms and clinical fields View source
Photobiomodulation: Lasers vs Light Emitting Diodes? A review addressing light sources and PBM parameters View source
Controlled trial of red and near-infrared light. A 2014 controlled trial evaluating complexion, skin feeling, roughness, collagen density, and fine lines View source
Reverse skin aging signs by red light photobiomodulation. A 2023 study of repeated red-LED facial treatment View source
Clinical and histological effects of blue and red LED phototherapy for acne. A randomized prospective study published in 2013 View source
Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis. A 2019 review noting both potential benefit and limitations in the evidence base View source
Light-emitting diodes in dermatology: A systematic review. An open-access systematic review of dermatologic LED applications View source
Note:
This material is provided for general educational purposes
and is not medical advice. Product benefits, directions, warnings,
contraindications, and regulatory status vary by device. Always follow the
manufacturer’s instructions and consult a qualified healthcare professional
regarding a medical condition, medication, photosensitivity, or whether light
therapy is appropriate for you.
CLARITY BEFORE COMMITMENT
Explore wavelengths, specifications, treatment protocols, and instructions with your goals in mind. For suitability or a skin condition, speak with a qualified health professional.
EXPLORE OUR COLLECTION
